Shi, Hongzhe
Cao, Chuanzhen
Wen, Li
Zhang, Lianyu
Zhang, Jin
Ma, Jianhui
Shou, Jianzhong
Li, Changling
Funding for this research was provided by:
Beijing hope run special fund of cancer foundation of China (LC2018L02)
Article History
Received: 18 December 2021
Accepted: 23 June 2022
First Online: 4 July 2022
Declarations
:
: The research study was reviewed and approved by the Cancer Hospital Chinese Academy of Medical Sciences of Ethics Committee (ID: NCC2016YJC-08). Patient details were anonymized before analysis. Patient written informed consent for treatment and follow-up was included in each medical record. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no conflicts of interests.